Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients
Completed · Phase 2
Conditions studied: HIV Infections
In brief
The purpose of this study is to see if it is safe and effective to add PMPA Prodrug (a new anti-HIV drug) to an anti-HIV drug combination taken by patients who have taken anti-HIV drugs in the past. Genetic response will be studied.
Key facts
- Study ID
- NCT00002415
- Run by
- Gilead Sciences
- People needed
- 175
- Last updated by the study team
- 2005-06-24
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- You may be eligible for this study if you:
- Are HIV-positive.
- Have an HIV count of 400 - 50,000 copies/ml.
- Are expected to live for at least 1 year.
- Have been taking the same anti-HIV drug combination (made up of no more than 3 anti-HIV drugs) for at least 8 weeks prior to study entry.
- Are at least 18 years old.
- Agree to use effective methods of birth control during the study.
You may not qualify if…
- You will not be eligible for this study if you:
- Have taken medications for certain infections within 15 days prior to study entry.
- Have a history of cancer, except Kaposi's sarcoma (KS) or skin cancer.
- Develop a new AIDS-related condition within 30 days of study entry.
- Have certain serious medical conditions, including severe nausea, vomiting, or other stomach problems that make you unable to take medications by mouth.
- Have received a vaccine within 30 days prior to study entry.
- Have taken certain medications, including those that may affect your kidneys.
- Abuse alcohol or drugs.
- Are pregnant.
Where it is running
- Univ of Alabama at Birmingham / 1917 Rsch Cln — Birmingham, Alabama, United States
- McDowell Clinic — Phoenix, Arizona, United States
- East Bay AIDS Ctr — Berkeley, California, United States
- Tower Infectious Disease Med Ctr — Los Angeles, California, United States
- UCSD Treatment Ctr — San Diego, California, United States
- San Francisco Veterans Adm Med Cntr — San Francisco, California, United States
- Harbor UCLA Med Ctr — Torrance, California, United States
- Univ of Colorado Health Sciences Ctr — Denver, Colorado, United States
- Hillsborough County Health Dept Special Care Ctr — Tampa, Florida, United States
- AIDS Research Consortium of Atlanta Inc — Atlanta, Georgia, United States
- Grady Mem Hosp — Atlanta, Georgia, United States
- Private Practice / Thacker and Thompson — Atlanta, Georgia, United States
- Northstar Med Clinic — Chicago, Illinois, United States
- CRI New England — Brookline, Massachusetts, United States
- Univ of Minnesota — Minneapolis, Minnesota, United States
- Beth Israel Med Ctr — New York, New York, United States
- Cornell Clinical Trials Unit - Chelsea Clinic — New York, New York, United States
- Univ Hosps of Cleveland — Cleveland, Ohio, United States
- The Research and Education Group — Portland, Oregon, United States
- Hershey Med Ctr — Hershey, Pennsylvania, United States
- Anderson Clinical Research — Pittsburgh, Pennsylvania, United States
- Roger Williams Med Ctr — Providence, Rhode Island, United States
- Amelia Ct Clinic — Dallas, Texas, United States
- Thomas Street Clinic — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.